MediPharm Labs Corp. LABS.TO
Set alert
As of Nov 2, 2:14 PM ET
- YTD
- -7.69%
- 1 year
- -20.00%
- Open
- 0.065
- Prev close
- 0.065
- Mkt cap
- 25.63M
- Vol
- 126.35K
- Avg vol
- 129.34K
- EPS
- -0.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.06
- High
- 0.065
- Forward P/E
- -6.00
- Beta
- 0.92
- Short ratio
- 1.31
- Inst. own
- 0.71%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.0696
- 200-d avg
- 0.07265
- 1y target
- 0.00
2Y chart
Signals (158)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 17 hours ago |
| MACD: Buy Signal | Oct 29, 2026 | 4 days ago |
| RSI: Oversold | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
Newest 20 of 158.
Key statistics
- Market cap
- 24.67M
- Enterprise value
- 15.12M
- Trailing P/E
- 0.00
- Forward P/E
- -6.00
- PEG ratio
- 0.00
- Price / sales
- 0.65
- Price / book
- 0.45
- EPS (TTM)
- -0.03
- Beta
- 0.92
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -35.25%
- Revenue (TTM)
- 37.76M
- Revenue growth
- 8.00%
- Free cash flow
- 7.26M
- Total cash
- 16.47M
- Total debt
- 2.81M
- Return on equity
- -24.96%
- Shares outstanding
- 411.12M
- Short % of float
- 0.00%
- 50-day average
- 0.0696
- 200-day average
- 0.07265
Analyst view
Consensus: none
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
About MediPharm Labs Corp.
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- medipharmlabs.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LABS.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gamma Investing LLC | 0.00% | 200 | 11 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify Seymour Cannabis ETF | 0.71% | 2,927,844 | 175.67K | Sep 29, 2024 |